CYTEIR THERAPEUTICS INC (CYTT)
Institutional ownership reported to the SEC as of Q1 2024, across 12 quarters.
4
Reporting holders
$11.0M
Reported value
0.0%
Held as options
-32
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| BML Capital Management, LLC | $11.0M | 3,654,053 | 7.25% | 5q | +12.4%+$1.2M |
| Lindbrook Capital, LLC | $6.0K | 2,006 | 0.00% | 7q | HELD |
| ACADIAN ASSET MANAGEMENT LLC | $77 | 26,319 | 0.00% | new | NEW |
| BOSTON FAMILY OFFICE LLC | $73 | 24,197 | 0.01% | 4q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2024 | 4 | $11.0M | 3,706,575 | 1 | 1 | 0 | 0.0% |
| Q4 2023 | 36 | $38.8M | 12,749,540 | 7 | 12 | 5 | 0.0% |
| Q3 2023 | 38 | $45.7M | 16,104,410 | 10 | 8 | 6 | 0.0% |
| Q2 2023 | 36 | $41.2M | 15,854,635 | 11 | 6 | 6 | 0.0% |
| Q1 2023 | 28 | $27.5M | 15,108,047 | 7 | 7 | 5 | 0.0% |
| Q4 2022 | 25 | $27.6M | 16,724,701 | 4 | 3 | 9 | 0.0% |
| Q3 2022 | 35 | $34.6M | 17,963,180 | 3 | 9 | 13 | 0.0% |
| Q2 2022 | 38 | $56.8M | 18,992,484 | 11 | 8 | 13 | 0.0% |
| Q1 2022 | 50 | $83.8M | 22,212,031 | 11 | 19 | 9 | 0.0% |
| Q4 2021 | 48 | $253.4M | 22,344,756 | 9 | 16 | 8 | 0.0% |
| Q3 2021 | 38 | $344.1M | 19,664,776 | 20 | 10 | 6 | 0.0% |
| Q2 2021 | 32 | $352.6M | 16,593,322 | 31 | 0 | 0 | 0.0% |